Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
alzheimer's disease
amgen
biotech
boston blog main
boston top stories
2
×
boulder/denver blog main
boulder/denver top stories
cystic fibrosis
deals
detroit blog main
2
×
detroit top stories
diagnostics
gilead sciences
indiana blog main
indiana top stories
life sciences
merck
national
national blog main
national top stories
new york blog main
new york top stories
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
2
×
wisconsin top stories
adverum biotechnologies
albert bourla
What
acquisitions
2
×
biggest
bio
ceo
drug
roundup
albert
bourla
build
buy
company
company’s
crispr
daniel
debut
dyne’s
future
gilead
imports
maker
maps
measured
microbiome
moves
openly
o’day
patients
pfizer
pfizer’s
pipeline
revenue
sciences
scores
seagen
spoken
today
way
week
world’s
Language
unknown
unset
Current search:
abbvie
×
acquisitions
×
" wisconsin blog main "
×
" boston top stories "
×
" detroit blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More